Pharming (PHAR) Short term Debt (2019 - 2020)

Pharming's Short term Debt history spans 2 years, with the latest figure at $24.3 million for Q4 2020.

  • Quarterly results put Short term Debt at $24.3 million for Q4 2020, up 22.95% from a year ago — trailing twelve months through Dec 2020 was $24.3 million (up 22.95% YoY), and the annual figure for FY2020 was $25.0 million, up 25.0%.
  • Short term Debt for Q4 2020 was $24.3 million at Pharming, up from $19.7 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $24.3 million in Q4 2020 to a low of $19.7 million in Q4 2019.